Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract

NCT00422877 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor suspended development of the drug on September 3, 2008.

Conditions

Cancer of the Liver

Interventions

DRUG: Taxoprexin

Sponsor

American Regent, Inc.